Endocrinology

Alemtuzumab-induced TED may develop many months after Graves’ disease

Alemtuzumab-induced thyroid eye disease (AI-TED) may develop several months after Graves' disease and can present with greater severity than conventional TED, according to a case series. In this retrospective case series, the clinical characteristics, imaging findings, and treatment for 5 patients with AI-TED were reviewed. At presentation, the average clinical...